Halting the Vicious Vortex: Case-based Discussions in Non-Cystic Fibrosis Bronchiectasis

Program Overview

Non-cystic fibrosis bronchiectasis (NCFBE) is an irreversible, chronic lung disease that is becoming increasingly prevalent and is a growing public concern. In this uniquely designed, interactive activity, a dynamic interprofessional panel of clinical experts will discuss NCFBE cases that have been crowdsourced from community clinicians, providing their insight on treatment strategies. Discussions between the 3 clinical experts will combine elements of evidence-based data and practical strategies to help you diagnose, treat, and monitor patients with NCFBE.

Credit Expired

Target Audience

Pulmonology, radiology, and primary care clinicians managing patients with NCFBE

Educational Objectives

Upon completion of this activity, participants should be better able to:

Identify patient-related risk factors that should raise the clinical index of suspicion for non-cystic fibrosis bronchiectasis (NCFBE)
Utilize current criteria to readily diagnose patients with NCFBE
Apply conventional management approaches in patients with NCFBE
Analyze data supporting the role of neutrophil serine protease (NSP) in NCFBE pathophysiology and its utility as therapeutic target
Integrate the unique roles of the interprofessional care team when diagnosing and treating patients with NCFBE

Activity Faculty

Ashwin Basavaraj, MD, FCCP, ATSF

Assistant Professor, Medicine
NYU Grossman School of Medicine
Section Chief, Pulmonary, Critical Care and Sleep Medicine
Bellevue Hospital Center
Associate Director, Bronchiectasis and NTM Program
NYU Langone Health
New York, NY

Charles L. Daley, MD

Chief, Division of Mycobacterials and Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO

Amy L. Springer, MSN, FNP-C

Pulmonary Nurse Practitioner
NYU Langone Health
New York, NY

Resources

Featured RMEI CE Activities – Earn CE Credit(s)

Halting the Vicious Vortex: Case-based Discussions in Non-Cystic Fibrosis Bronchiectasis

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Ashwin Basavaraj, MD, FCCP, ATSF

Charles L. Daley, MD

Amy L. Springer, MSN, FNP-C

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care: A Care Team Forum®

Refining Management of CMV After Transplant: Exploiting Recent Advances to Alleviate Patient Burden

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Subscribe